{"id":"https://openalex.org/W2086922191","doi":"https://doi.org/10.1517/14740338.5.1.145","title":"Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions","display_name":"Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions","alternate_titles":[],"publication_year":2005,"publication_date":"2005-12-22","ids":{"openalex":"https://openalex.org/W2086922191","doi":"https://doi.org/10.1517/14740338.5.1.145","mag":"2086922191","pmid":"https://pubmed.ncbi.nlm.nih.gov/16370963"},"language":"en","primary_location":{"id":"doi:10.1517/14740338.5.1.145","doi":"https://doi.org/10.1517/14740338.5.1.145","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.5.1.145","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2086922191"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103535357","display_name":"Michael H Davidson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]},{"id":"https://openalex.org/I49886154","display_name":"Rush University","ror":"https://ror.org/01k9xac83","country_code":"US","type":"education","lineage":["https://openalex.org/I49886154"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael H Davidson","raw_affiliation_strings":["Rush University, Preventive Cardiology Center, Rush-Presbyterian-St. Luke's Medical Center, 515 State Street, Suite 2700, Chicago, IL, USA. michaeldavidson@radiantresearch.com","Rush University, Preventive Cardiology Center, Rush-Presbyterian-St. Luke's Medical Center, 515 State Street, Suite 2700, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rush University, Preventive Cardiology Center, Rush-Presbyterian-St. Luke's Medical Center, 515 State Street, Suite 2700, Chicago, IL, USA. michaeldavidson@radiantresearch.com","institution_ids":["https://openalex.org/I1285301757","https://openalex.org/I49886154"]},{"raw_affiliation_string":"Rush University, Preventive Cardiology Center, Rush-Presbyterian-St. Luke's Medical Center, 515 State Street, Suite 2700, Chicago, IL, USA","institution_ids":["https://openalex.org/I1285301757","https://openalex.org/I49886154"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103535357"],"corresponding_institution_ids":["https://openalex.org/I1285301757","https://openalex.org/I49886154"],"apc_list":null,"apc_paid":null,"fwci":1.4967,"has_fulltext":false,"cited_by_count":79,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8159862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"5","issue":"1","first_page":"145","last_page":"156"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.08590000122785568,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statin-fibrate-combination-therapy","display_name":"statin-fibrate combination therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.878000020980835},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.8140000104904175},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":0.9309999942779541},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":1.0},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8410000205039978},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.8420000076293945},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myotoxicity","display_name":"myotoxicity","score":0.925000011920929},{"id":"https://openalex.org/keywords/statin-exposure","display_name":"statin exposure","score":0.6019999980926514},{"id":"https://openalex.org/keywords/accord-trial","display_name":"ACCORD trial","score":0.722000002861023},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.6790000200271606},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9738088846206665},{"id":"https://openalex.org/C2778670441","wikidata":"https://www.wikidata.org/wiki/Q384295","display_name":"Gemfibrozil","level":3,"score":0.9337531328201294},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9055414199829102},{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.8350859880447388},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6907257437705994},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6121453046798706},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5587862133979797},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5287843346595764},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5258907675743103},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48461946845054626},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.476151704788208},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.43137621879577637},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.41098737716674805},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.39699769020080566},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2816145420074463}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002995","descriptor_name":"Clofibric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002995","descriptor_name":"Clofibric Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002995","descriptor_name":"Clofibric Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015248","descriptor_name":"Gemfibrozil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015248","descriptor_name":"Gemfibrozil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015248","descriptor_name":"Gemfibrozil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/14740338.5.1.145","doi":"https://doi.org/10.1517/14740338.5.1.145","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.5.1.145","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},{"id":"pmid:16370963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16370963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W152448817","https://openalex.org/W166913989","https://openalex.org/W1502524639","https://openalex.org/W1558276030","https://openalex.org/W1791318806","https://openalex.org/W1934270266","https://openalex.org/W1969054950","https://openalex.org/W1971213885","https://openalex.org/W1975089198","https://openalex.org/W1985258130","https://openalex.org/W1988048988","https://openalex.org/W1992918939","https://openalex.org/W2003602721","https://openalex.org/W2010241890","https://openalex.org/W2010708076","https://openalex.org/W2012793432","https://openalex.org/W2025607667","https://openalex.org/W2026628186","https://openalex.org/W2027573911","https://openalex.org/W2028211844","https://openalex.org/W2028384112","https://openalex.org/W2028468709","https://openalex.org/W2029471511","https://openalex.org/W2030059253","https://openalex.org/W2032320739","https://openalex.org/W2033524588","https://openalex.org/W2035104517","https://openalex.org/W2042875425","https://openalex.org/W2046285201","https://openalex.org/W2051922899","https://openalex.org/W2053536280","https://openalex.org/W2055974197","https://openalex.org/W2059863792","https://openalex.org/W2065986416","https://openalex.org/W2079872539","https://openalex.org/W2082680963","https://openalex.org/W2084805047","https://openalex.org/W2088928036","https://openalex.org/W2100744461","https://openalex.org/W2102504779","https://openalex.org/W2106343349","https://openalex.org/W2114814512","https://openalex.org/W2127191771","https://openalex.org/W2130875981","https://openalex.org/W2137914533","https://openalex.org/W2143272453","https://openalex.org/W2150797190","https://openalex.org/W2151471516","https://openalex.org/W2158607621","https://openalex.org/W2160945880","https://openalex.org/W2163014581","https://openalex.org/W2163711771","https://openalex.org/W2166910397","https://openalex.org/W2169033201","https://openalex.org/W2403435542","https://openalex.org/W2604232906"],"related_works":["https://openalex.org/W2137739219","https://openalex.org/W1984684948","https://openalex.org/W2043626423","https://openalex.org/W2887804496","https://openalex.org/W2018768201","https://openalex.org/W2384361126","https://openalex.org/W2905904043","https://openalex.org/W2142818580","https://openalex.org/W2103428308","https://openalex.org/W2051800461"],"abstract_inverted_index":{"Patients":[0],"with":[1,48,66,101,170,191],"the":[2,31,42,61,128,132,140,151,156,198],"metabolic":[3,89],"syndrome":[4],"and/or":[5],"Type":[6,192],"2":[7,193],"diabetes":[8,194],"mellitus":[9,195],"continue":[10],"to":[11,78,83,121,134,163,175,180],"have":[12],"a":[13,107,119],"high":[14,54,67],"risk":[15,55],"of":[16,23,44,56,85,142,155,202],"coronary":[17],"heart":[18],"disease":[19],"(CHD)":[20],"and":[21,69,90,130,200],"progression":[22],"atherosclerotic":[24],"lesions":[25],"despite":[26],"aggressive":[27],"statin":[28,125],"therapy.":[29],"Although":[30],"National":[32],"Cholesterol":[33],"Education":[34],"Programme":[35],"Adult":[36],"Treatment":[37],"Panel":[38],"III":[39],"guidelines":[40],"recommend":[41],"use":[43,79],"fibrates":[45],"in":[46,50,99,124,184,188],"combination":[47,100,172],"statins":[49,105,157],"patients":[51,59,190],"at":[52,60],"very":[53],"CHD":[57],"(e.g.,":[58],"low-density":[62],"lipoprotein":[63,72],"cholesterol":[64],"target":[65],"triglycerides":[68],"low":[70],"high-density":[71],"cholesterol,":[73],"many":[74,135],"physicians":[75],"remain":[76],"reluctant":[77],"these":[80,114],"combinations":[81],"due":[82],"concerns":[84],"myotoxicity.":[86],"Recently":[87],"conducted":[88],"pharmacokinetic":[91,160],"drug-drug":[92],"interaction":[93,111],"studies":[94],"using":[95],"gemfibrozil":[96],"or":[97,153],"fenofibrate":[98,145],"five":[102],"commonly":[103],"used":[104],"demonstrated":[106],"widely":[108],"different":[109],"drug":[110],"potential":[112,167],"for":[113,139,168],"two":[115],"fibrates.":[116],"Gemfibrozil":[117],"causes":[118],"2-":[120],"6-fold":[122],"increase":[123],"area":[126],"under":[127],"curve":[129],"increases":[131],"exposure":[133],"recently":[136],"approved":[137],"drugs":[138],"treatment":[141],"diabetes.":[143],"Alternatively,":[144],"does":[146],"not":[147],"adversely":[148],"affect":[149],"either":[150],"metabolism":[152],"pharmacokinetics":[154],"studied.":[158],"These":[159],"differences":[161],"appear":[162],"translate":[164],"into":[165],"less":[166],"interactions":[169],"fenofibrate/statin":[171,203],"therapy":[173],"compared":[174],"gemfibrozil/statin":[176],"co-administration.":[177],"The":[178],"Action":[179],"Control":[181],"Cardiovascular":[182],"Risk":[183],"Diabetes":[185],"(ACCORD)":[186],"study":[187],"10,000":[189],"is":[196],"testing":[197],"efficacy":[199],"safety":[201],"combination.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2086922191","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
